Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Anthem's profits dropped in Q2, but still tallied $1.8 billion. Photo: Michael Nagle/Bloomberg via Getty Images

Anthem is "going to continue to evaluate" the data around Aduhelm, the controversial Alzheimer's drug, before making final insurance coverage decisions, CEO Gail Boudreaux told investors Wednesday.

Why it matters: Several other Blue Cross Blue Shield insurers have said they will not cover Aduhelm, but Anthem is still weighing the options like its competitor UnitedHealth, which also wants to wait and see what the federal government says.

By the numbers: Anthem's revenue in the second quarter increased 16% year over year, totaling almost $34 billion.

  • Profit was down 21% from the same period last year, hitting $1.8 billion. Similar to UnitedHealth, more patients got care this year whereas the pandemic kept most people indoors and away from doctors last year.
  • Anthem now insures 44.3 million people, up 4.4% from a year ago. But most of those gains came in its private Medicare and Medicaid plans. Anthem continues to lose people in job-based plans.

Go deeper

Jul 14, 2021 - Health

What to watch for during health care's Q2 earnings

Illustration: Sarah Grillo/Axios

Corporate America is expecting big jumps in profits in the second quarter. That's especially the case in health care, an industry that hasn't really lost a lot of financial momentum throughout the coronavirus pandemic.

The bottom line: Health care spending is basically back to pre-COVID levels. Expect big numbers across the board.

Jul 21, 2021 - Health

The great patient influx

HCA's Medical Center of Trinity in Florida. Photo: Eve Edelheit/Bloomberg via Getty Images

If HCA Healthcare's second-quarter earnings are any kind of bellwether for hospital systems, then it's clear patients came back in droves to get emergency care or elective care that had to be delayed because of the coronavirus pandemic.

The big picture: "Our volume, as indicated in the second quarter, will return to 2019 levels and perhaps moderately above that," HCA's CFO Bill Rutherford told investors.

Mike Allen, author of AM
27 mins ago - Politics & Policy

America's "Friendscape" crisis

New research shows Americans have fewer friends than in the past, and are less likely to have a best friend.

  • Why it matters: At a time of excruciating mental and societal stress, this is another sign we're breaking apart. And the friendship drought could get worse with more people working remotely or hybrid-ly.